UnitedHealth Group's Q1 2018 earnings call revealed strong performance across its businesses, with 13% revenue growth and 28% adjusted earnings growth. The company's Optum segment drove double-digit growth, while UnitedHealthcare continued to deliver distinctive performance in Medicare Advantage and Medicaid. Management raised its full-year adjusted earnings outlook, citing the company's diversified business portfolio and opportunities for growth. The tone of the call was positive, with management expressing confidence in the company's ability to drive long-term growth and returns.

[2]